Levosimendan use in patients with acute heart failure and reduced ejection fraction with or without severe renal dysfunction in critical cardiac care units: a multi-institution database study

BACKGROUND: Acute heart failure is a life-threatening clinical condition. Levosimendan is an effective inotropic agent used to maintain cardiac output, but its usage is limited by the lack of evidence in patients with severely abnormal renal function. Therefore, we analyzed data of patients with acu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Cze-Ci, Lee, Kuang-Tso, Ho, Wan-Jing, Chan, Yi-Hsin, Chu, Pao-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869075/
https://www.ncbi.nlm.nih.gov/pubmed/33555483
http://dx.doi.org/10.1186/s13613-021-00810-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869075/
https://www.ncbi.nlm.nih.gov/pubmed/33555483
http://dx.doi.org/10.1186/s13613-021-00810-y

Ejemplares similares